Evidence map›Paper›PMID 42079062›Full record

ArticlebioRxiv : the preprint server for biology2026

Chromosome-arm-specific telomere length governs dual modes of structural genome evolution in IDH-mutant astrocytoma.

Maryam Jehangir, Kristen L Drucker, Ayse Keskus, T Rhyker Ranallo-Benavidez, Orlena Benamozig, Thomas Kollmeyer, Terry C Burns, Caterina Giannini, Benjamin R Kipp, Stephen J Murphy and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maryam JehangirDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.ORCID 0000-0001-5121-770X
Kristen L DruckerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-6244-5863
Ayse KeskusCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.ORCID 0000-0002-3934-8587
T Rhyker Ranallo-BenavidezDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.ORCID 0000-0003-3137-8439
Orlena BenamozigDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0009-0002-5250-748X
Thomas KollmeyerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0694-3224
Terry C BurnsDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.
Caterina GianniniDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-2757-6782
Benjamin R KippDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9477-0118
Stephen J MurphyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Amber R BridgemanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-0499-3954
Jesse R WalshDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-6048-1166
Ramanath MajumdarDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Daniel LachanceDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-8653-2259
Jeanette Eckel-PassowDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-6113-1114
Ofer ShoshaniDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-8918-9935
Mikhail KolmogorovCancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.ORCID 0000-0002-5489-9045
Robert B JenkinsDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Floris P BarthelDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.ORCID 0000-0002-7425-4180

Funding

UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMASR01CA230712 · NCI · MAYO CLINIC ROCHESTER · PI JENKINS, ROBERT B. · 2018 to 2022
$3.3M
Using germline and somatic genetics to elucidate glioma risk and improve patient outcomesR01CA298083 · NCI · MAYO CLINIC ROCHESTER · PI JEANETTE E ECKEL PASSOW, ROBERT B. JENKINS · 2025 to 2026
$954k
NCI NIH HHS R01 CA230712NCI NIH HHS R01 CA298083
6 · The paper itself

Abstract

IDH-mutant astrocytomas maintain telomeres through the alternative lengthening of telomeres (ALT) pathway, producing extreme inter-arm telomere length heterogeneity, yet how this heterogeneity shapes structural genome evolution remains unknown. Using Oxford Nanopore long-read sequencing of 20 IDH-mutant astrocytomas, we profiled structural variants (SVs), copy number variants, extrachromosomal DNA (ecDNA) and measured allele-specific telomere lengths from individual long reads. We identified pervasive complex rearrangements, including chromothripsis and foldback events consistent with breakage-fusion-bridge cycles, and widespread ecDNAs. SV breakpoints were enriched at telomeric and centromeric regions regardless of local telomere length, revealing constitutive structural fragility. Arm-level telomere length analysis uncovered a dual-mode model: arms with short telomeres preferentially harbored breakage-associated events, while arms with long ALT-maintained telomeres were enriched for ecDNA and amplification-associated events. These findings identify chromosome-arm-specific telomere length as a determinant of structural genome evolution in ALT-driven tumors.

Identifiers

PMID42079062
PMCPMC13131789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.